Expanding Seniors’ Access to PFAS Testing Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
95pct
510d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2024 · fourth_quarter · Medicare/Medicaid
P.L. 118-83/H.R. 9747- Continuing Appropriations and Extensions Act, 2025 , provisions related to Medicare reimbursement for clinical diagnostics laboratory services H.R. 2377/S. 1000 - Saving Access to Laboratory Services Act, provisions related to Medicare reimbursement for clinical diagnostics laboratory services P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024 H.R. 4917 - Expanding Seniors Access to PFAS Testing Act H.R. 8702 - Improving Seniors Timely Access to Care Act H.R. 8839 - Maternal and Infant Syphilis Prevention Act Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: $390,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · first_quarter · Medicare/Medicaid
P.L. 117-328/H.R. 2617- Consolidated Appropriations Act of 2023, provisions related to Medicare reimbursement for clinical diagnostics laboratory services H.R. 2377/S. 1000 - Saving Access to Laboratory Services Act, provisions related to Medicare reimbursement for clinical diagnostics laboratory services P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024 H.R. 4917 - Expanding Seniors Access to PFAS Testing Act Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program
Client expense: $430,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · third_quarter · Medicare/Medicaid
P.L. 118-83/H.R. 9747- Continuing Appropriations and Extensions Act, 2025 , provisions related to Medicare reimbursement for clinical diagnostics laboratory services H.R. 2377/S. 1000 - Saving Access to Laboratory Services Act, provisions related to Medicare reimbursement for clinical diagnostics laboratory services P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024 H.R. 4917 - Expanding Seniors Access to PFAS Testing Act H.R. 8702 - Improving Seniors Timely Access to Care Act H.R. 8839 - Maternal and Infant Syphilis Prevention Act Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program
Client expense: $410,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · second_quarter · Medicare/Medicaid
P.L. 117-328/H.R. 2617- Consolidated Appropriations Act of 2023, provisions related to Medicare reimbursement for clinical diagnostics laboratory services H.R. 2377/S. 1000 - Saving Access to Laboratory Services Act, provisions related to Medicare reimbursement for clinical diagnostics laboratory services P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024 H.R. 4917 - Expanding Seniors Access to PFAS Testing Act H.R. 8702 - Improving Seniors Timely Access to Care Act Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program
Client expense: $520,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · first_quarter · Medicare/Medicaid
P.L. 117-328/H.R. 2617- Consolidated Appropriations Act of 2023, provisions related to Medicare reimbursement for clinical diagnostics laboratory services H.R. 2377/S. 1000 - Saving Access to Laboratory Services Act, provisions related to Medicare reimbursement for clinical diagnostics laboratory services P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024 H.R. 4917 - Expanding Seniors Access to PFAS Testing Act Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program
Client expense: $520,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · fourth_quarter · Medicare/Medicaid
P.L. 117-328/H.R. 2617- Consolidated Appropriations Act of 2023, provisions related to Medicare reimbursement for clinical diagnostics laboratory services H.R. 2377/S. 1000 - Saving Access to Laboratory Services Act, provisions related to Medicare reimbursement for clinical diagnostics laboratory services P.L. 118-22/H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024 H.R. 4917 - Expanding Seniors Access to PFAS Testing Act Federal policy related to coverage and reimbursement of clinical laboratory services under the Medicare program
Client expense: $530,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · fourth_quarter · Consumer Issues/Safety/Products
H.R.4917 - Expanding Seniors Access to PFAS Testing Act Forced Arbitration Injustice Repeal Act (FAIR). Protecting the Employment Rights of Service Members Act (PERSA). Justice for Servicemembers Act. Fairness in Nursing Home Arbitration Act. Bill to prohibit forced arbitration in health insurance contracts. PFAS Accountability Act. Nursing Home Improvement and Accountability Act. National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration, MCA claims, and cyber incident reporting. National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration. SPEAK OUT Act. Consolidated Appropriations Act, 2023, with regard to cosmetics legislation. Updated Drug labeling for Patient Safety Act. Protecting Older Americans Act Ending Forced Arbitration of Race Discrimination Act of 2023 Draft legislation on PFAS. Draft asbestos ban legislation. Draft generic drug labeling legislation. Draft dietary supplement legislation. General lobbying on ending the use of forced arbitration for consumers and workers. General lobbying with regard to forced arbitration in nursing homes. General lobbying with regard to e-cigarettes safety and regulation. General lobbying with regard to the FDA proposal regarding the testing of talc for asbestos. General lobbying with regard to FIFRA preemption and Monsanto Company v. Hardeman preemption case. General lobbying with regard to glyphosate safety. General lobbying with regard to drug pricing. S. 269: Protect America's Children from Toxic Pesticides Act HR 4417/S2019 Ending Agricultural Trade Suppression
Client expense: $1,380,000 · Firm income: Not reported
2023 · third_quarter · Consumer Issues/Safety/Products
H.R.4917 - Expanding Seniors Access to PFAS Testing Act Forced Arbitration Injustice Repeal Act (FAIR). Protecting the Employment Rights of Service Members Act (PERSA). Justice for Servicemembers Act. Fairness in Nursing Home Arbitration Act. Bill to prohibit forced arbitration in health insurance contracts. PFAS Accountability Act. Nursing Home Improvement and Accountability Act. National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration, MCA claims, and cyber incident reporting. National Defense Authorization Act, with specific regard to amendments on SCRA and USERRA forced arbitration. SPEAK OUT Act. FDA Safety and Landmark Advancements Act. Consolidated Appropriations Act, 2023, with regard to cosmetics legislation. Updated Drug labeling for Patient Safety Act. Protecting Older Americans Act Ending Forced Arbitration of Race Discrimination Act of 2023 Draft legislation on PFAS. Draft asbestos ban legislation. Draft generic drug labeling legislation. Draft cosmetics reform legislation. Draft dietary supplement legislation. General lobbying on ending the use of forced arbitration for consumers and workers. General lobbying with regard to forced arbitration in nursing homes. General lobbying with regard to COVID-19 liability. General lobbying with regard to e-cigarettes safety and regulation. General lobbying with regard to the FDA proposal regarding the testing of talc for asbestos. General lobbying with regard to FIFRA preemption and Monsanto Company v. Hardeman preemption case. General lobbying with regard to glyphosate safety. General lobbying with regard to drug pricing. S. 269: Protect America's Children from Toxic Pesticides Act HR 4417/S2019 Ending Agricultural Trade Suppression
Client expense: $1,270,000 · Firm income: Not reported
| Democratic |
| NH |
| James C. Moylan | Republican | GU |
| Nancy Mace | Republican | SC |
| Raúl M. Grijalva | Democratic | AZ |
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE